Peachman Revenues for the preceding quarter were down from about 13.4 million dollars to 8.3 million dollars, which is about 5 million dollars. Sheriff has proved to have been in contact with a good source. The same goes for the poster who stated sales had been weak (he used a different word.
Yep... and begin the getting caught up in stem cell revenue discussion all over again, lol. I for one am not nor have ever been an investor because of those products. They are a good interim source of cash and means to develop a sales/support team.
That said, there are always headwinds in industries - key for those that care will be to compare PREDs segment growth relative to competition.